Company: TAK
Filing Date: 2025-10-30
Form Type: 6-K
Source: 0001395064-25-000152
Chunk: 15

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-10-30
Form: 6-K
Chunk 15
---
 International Financial Reporting Standards (IFRS). See “Definition and Explanation of Non-IFRS Measures and U.S. Dollar Convenience Translations” in the Financial Appendix for additional information.

#### Results of Core Operations
|                                                                      |     |           |         |     |            |         |     |          |        |     |          |       |   |     |     |       | Billion JPY or percentage |
|                                                                      |     | FY2024 H1 |         |     | FY2025 H1  |         |     | AER      |        |     |          |       |   |     | CER |       |                           |
|                                                                      |     |           |         |     | JPY Change |         |     | % Change |        |     | % Change |       |   |     |     |       |                           |
| Core revenue                                                         |     |           | 2,384.0 |     |            | 2,219.5 |     |          | -164.5 |     |          |  -6.9 | % |     |     |  -3.9 | %                         |
| Core operating profit                                                |     |           |   719.9 |     |            |   639.2 |     |          |  -80.7 |     |          | -11.2 | % |     |     |  -8.8 | %                         |
| Core net profit for the period                                       |     |           |   489.2 |     |            |   438.7 |     |          |  -50.5 |     |          | -10.3 | % |     |     | -11.1 | %                         |
| Core net profit for the period attributable to owners of the Company |     |           |   489.1 |     |            |   438.6 |     |          |  -50.5 |     |          | -10.3 | % |     |     | -11.1 | %                         |
| Core EPS (yen)                                                       |     |           |     310 |     |            |     279 |     |          |    -31 |     |          | -10.0 | % |     |     | -10.8 | %                         |

#### Core Revenue
Core Revenue was JPY 2,219.5 billion (JPY -164.5 billion and -6.9% AER, -